Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04652375 · ClinicalTrials.gov registry record · NA
Outcomes After Albumin Vs Lactated Ringer's Solution in CABG and AVR Procedures
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 131
- Enrollment target
NCT04652375 is a NA study that has completed, run by Yale University. The registered enrollment target is 131 participants.
The verdict
NCT04652375, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 131 participants
- Enrollment target
Study Summary
This is a prospective, randomized, double-blinded study to compare the use of albumin versus lactated Ringer's solution in patients undergoing coronary artery bypass graft surgery and in patients undergoing aortic valve replacement surgery and evaluate the incidence of acute kidney injury as a primary outcome.
Interventions
- OTHER Albumin Solution
- OTHER Lactated Ringer's Solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 131 participants |
| Start Date | 2021-07-01 |
| Est. Completion | 2022-07-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04652375
The ClinicalTrials.gov registry entry for NCT04652375 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 131 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Albumin Solution is the first listed.
NCT04652375 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04652375 about?
NCT04652375 is a clinical study titled "Outcomes After Albumin Vs Lactated Ringer's Solution in CABG and AVR Procedures". This is a prospective, randomized, double-blinded study to compare the use of albumin versus lactated Ringer's solution in patients undergoing coronary artery bypass graft surgery and in patients undergoing aortic valve replacement surgery and evaluate the incidence of acute kidney injury as a prima...
What is the current status of trial NCT04652375?
This trial is currently completed. It is a NA study. The enrollment target is 131 participants. The study started on 2021-07-01. Estimated completion is 2022-07-26.
What interventions are being tested in trial NCT04652375?
The interventions under investigation include: Albumin Solution (OTHER), Lactated Ringer's Solution (OTHER).
Who is sponsoring clinical trial NCT04652375?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.